{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:45:53Z","timestamp":1791895553047,"version":"4.3.4"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jaad.2016.08.053","type":"journal-article","created":{"date-parts":[[2016,10,28]],"date-time":"2016-10-28T10:30:26Z","timestamp":1477650626000},"page":"33-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Olumacostat glasaretil, a novel topical sebum inhibitor, in the treatment of acne vulgaris: A phase IIa, multicenter, randomized, vehicle-controlled study"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5927-6587","authenticated-orcid":false,"given":"Robert","family":"Bissonnette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Poulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Drew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Hofland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2016.08.053_bib1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(11)60321-8","article-title":"Acne vulgaris","volume":"379","author":"Williams","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2016.08.053_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archfami.9.2.179","article-title":"New treatments and therapeutic strategies for acne","volume":"9","author":"Thiboutot","year":"2000","journal-title":"Arch Fam Med"},{"key":"10.1016\/j.jaad.2016.08.053_bib3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2133.2010.09878.x","article-title":"Can sebum reduction predict acne outcome?","volume":"163","author":"Janiczek-Dolphin","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.08.053_bib4","first-page":"1","article-title":"Acne in adolescents: quality of life, self-esteem, mood, and psychological disorders","volume":"17","author":"Dunn","year":"2011","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaad.2016.08.053_bib5","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM199704173361607","article-title":"Therapy for acne vulgaris","volume":"336","author":"Leyden","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2016.08.053_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev.nutr.17.1.77","article-title":"Regulation of mammalian acetyl-coenzyme A carboxylase","volume":"17","author":"Kim","year":"1997","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.jaad.2016.08.053_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1517\/14728222.9.2.267","article-title":"Treating the metabolic syndrome: acetyl-CoA carboxylase inhibition","volume":"9","author":"Harwood","year":"2005","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jaad.2016.08.053_bib8","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1007\/s00018-005-5121-4","article-title":"Acetyl-coenzyme A carboxylase: crucial metabolic enzyme and attractive target for drug discovery","volume":"62","author":"Tong","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jaad.2016.08.053_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1997.00001.x","article-title":"The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis","volume":"244","author":"McGarry","year":"1997","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jaad.2016.08.053_bib10","doi-asserted-by":"crossref","first-page":"37099","DOI":"10.1074\/jbc.M304481200","article-title":"Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals","volume":"278","author":"Harwood","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaad.2016.08.053_bib11","unstructured":"US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for Industry. Acne vulgaris: developing drugs for treatment. September 2005."},{"key":"10.1016\/j.jaad.2016.08.053_bib12","first-page":"S70","article-title":"DRM01, a novel acetyl coenzyme A carboxylase (ACC) inhibitor, reduces sebum production","volume":"134","author":"Hunt","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"suppl 1","key":"10.1016\/j.jaad.2016.08.053_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2011.04374.x","article-title":"European evidence-based (S3) guidelines for the treatment of acne","volume":"26","author":"Nast","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2016.08.053_bib14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaad.2009.01.019","article-title":"Global Alliance to Improve Outcomes in Acne. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group","volume":"60","author":"Thiboutot","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.08.053_bib15","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jaad.2008.06.040","article-title":"An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients","volume":"59","author":"Thiboutot","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.08.053_bib16","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0190-9622(97)70177-4","article-title":"Treatment of acne with a combination clindamycin\/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations","volume":"37","author":"Lookingbill","year":"1997","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221630740X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221630740X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:40:56Z","timestamp":1759272056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096221630740X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S019096221630740X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2016.08.053","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Olumacostat glasaretil, a novel topical sebum inhibitor, in the treatment of acne vulgaris: A phase IIa, multicenter, randomized, vehicle-controlled study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2016.08.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}